Novo’s Wegovy cleared by UK drug price watchdog for heart disease, expanding access by 1.2 million people

URL has been copied successfully!

The new recommendation will significantly expand access to Wegovy on England’s NHS.

Please follow us:
Follow by Email
X (Twitter)
Whatsapp
LinkedIn
Copy link

This post was originally published here